HLA-E: An Immune Molecule That Could Enable Universal Vaccines and Cancer Immunotherapies
HLA-E's ability to present pathogen-derived peptides to immune cells makes it a promising target for broadly applicable vaccines and immunotherapies that work across diverse populations.
Quick Facts
What This Study Found
HLA-E can present pathogen-derived peptides to CD8+ T cells, eliciting cytotoxic immune responses, and its minimal polymorphism makes it an ideal target for universally applicable vaccines and immunotherapies.
Key Numbers
No specific clinical data; reviews immunological mechanisms and emerging therapeutic platforms.
How They Did This
Review of published literature on HLA-E biology, HLA-E-restricted T cell responses in infections, and therapeutic applications in vaccine and immunotherapy development.
Why This Research Matters
Universal immune targets like HLA-E could solve the fundamental challenge of HLA diversity that limits current vaccine and immunotherapy effectiveness across populations.
The Bigger Picture
HLA-E-targeted approaches represent a paradigm shift in immunology — moving from personalized, HLA-matched treatments toward universal platforms that could provide equitable immune protection regardless of genetic background.
What This Study Doesn't Tell Us
Much HLA-E research is still preclinical; the breadth of pathogen peptides presented by HLA-E and the strength of resulting immune responses need further characterization.
Questions This Raises
- ?Can HLA-E-targeted vaccines provide durable protection comparable to classical HLA-restricted responses?
- ?How can HLA-E-based cancer immunotherapies be combined with existing checkpoint inhibitors?
Trust & Context
- Key Stat:
- Near-universal HLA-E has minimal genetic variation, making it a target for vaccines that work in all people
- Evidence Grade:
- Review of emerging research; HLA-E biology is well-established but therapeutic applications are largely preclinical or early-stage.
- Study Age:
- Published in 2025, capturing the latest advances in HLA-E-restricted immunity and therapeutic development.
- Original Title:
- The Expanding Role of HLA-E in Host Defense: A Target for Broadly Applicable Vaccines and Immunotherapies.
- Published In:
- Cells, 14(24) (2025)
- Authors:
- Rafieiyan, Mahsa, La Manna, Marco Pio, Dieli, Francesco, Caccamo, Nadia, Badami, Giusto Davide
- Database ID:
- RPEP-13168
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
What is HLA-E and why does it matter for vaccines?
HLA-E is an immune molecule that is nearly identical in all humans, unlike other HLA molecules that vary widely. Because it can present pieces of viruses and bacteria to immune cells, targeting HLA-E could enable vaccines that work for everyone regardless of genetic background.
How could HLA-E help with cancer treatment?
HLA-E-based immunotherapies could potentially activate immune responses against cancer cells in all patients, overcoming the limitation of current approaches that depend on each patient's specific HLA type for effectiveness.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13168APA
Rafieiyan, Mahsa; La Manna, Marco Pio; Dieli, Francesco; Caccamo, Nadia; Badami, Giusto Davide. (2025). The Expanding Role of HLA-E in Host Defense: A Target for Broadly Applicable Vaccines and Immunotherapies.. Cells, 14(24). https://doi.org/10.3390/cells14241983
MLA
Rafieiyan, Mahsa, et al. "The Expanding Role of HLA-E in Host Defense: A Target for Broadly Applicable Vaccines and Immunotherapies.." Cells, 2025. https://doi.org/10.3390/cells14241983
RethinkPeptides
RethinkPeptides Research Database. "The Expanding Role of HLA-E in Host Defense: A Target for Br..." RPEP-13168. Retrieved from https://rethinkpeptides.com/research/rafieiyan-2025-the-expanding-role-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.